These motivating results resulted in randomized controlled trials evaluating the result of rituximab like a remission induction therapy in individuals with serious AAV (“type”:”clinical-trial”,”attrs”:”text”:”NCT00104299″,”term_id”:”NCT00104299″NCT00104299, “type”:”clinical-trial”,”attrs”:”text”:”NCT01731561″,”term_id”:”NCT01731561″NCT01731561)
These motivating results resulted in randomized controlled trials evaluating the result of rituximab like a remission induction therapy in individuals with serious AAV ("type":"clinical-trial","attrs":"text":"NCT00104299","term_id":"NCT00104299"NCT00104299, "type":"clinical-trial","attrs":"text":"NCT01731561","term_id":"NCT01731561"NCT01731561). FVIIa in pediatric individuals will be discussed at length. spp. Broad-spectrum antibiotics CMV and herpes pneumonitis Diffuse alveolar damageRadiation Antifungal real estate agents Cytotoxic medicines Acute respiratory stress symptoms Antiviral therapy Hematopoietic stem cell transplantation Idiopathic pulmonary hemosiderosis Diuresis Cardiovascular diseasePulmonary SOS Kerley B lines on upper body radiograph Mitral stenosis Cardiac medical marketing Arteriovenous malformation Pulmonary lymphangiomyomatosis Pulmonary hypertension Pulmonary capillary hemangiomatosis Remaining ventricular dysfunction Open up in another windowpane Abbreviations: ANA, anti-nuclear antibody; ANCA, anti-neutrophil cytoplasmic antibody; anti-2GPA, anti--2 glycoprotein1 antibody; anti-CL antibody, anti-cardiolipin antibody; anti-dsDNA antibody, anti-double stranded DNA antibody; anti-MPO, anti-myeloperoxidase antibody; APL, anti-phospholipid antibody; anti-SM antibody; anti-smooth muscle tissue antibody;…